+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states



Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states



Journal of Clinical Endocrinology and Metabolism 92(6): 2223-2231



Primary GH insensitivity (GHI) or Laron syndrome, caused by mutations of the GH receptor (GHR) gene, has a clinical phenotype of postnatal growth failure associated with normal elevated serum concentrations of GH and low serum levels of IGF-I. We investigated the clinical and biochemical implications of molecular defects in the GHR gene in an Austrian family with two daughters who were GHI. Patient 1 [height, -4.8 sd score (SDS)] and patient 2 (height, -5.0 SDS) had elevated circulating levels of GH, low-normal levels of GH-binding protein, and abnormally low IGF-I (-5.0 SDS and -2.6 SDS, respectively) and IGF-binding protein-3 (-2.6 SDS and -2.0 SDS, respectively). Both patients carry novel compound, missense, heterozygous GHR mutations, C94S and H150Q. In vitro reconstitution experiments demonstrated that whereas each of the mutants could be stably expressed, GHR(C94S) lost its affinity for GH and could neither activate signal transducer and activator of transcription (STAT)-5b nor drive STAT5b-dependent gene transcription in response to GH (1-100 ng/ml). GHR(H150Q) showed normal affinity for GH but impaired capacity for signal transduction. The compound heterozygote and C94S heterozygote, but not the H150Q heterozygote, showed significant deficiency in activating GH-induced gene expression, corroborating diminished GH-induced STAT5b activation in fibroblasts carrying GHR(C94S) as either a compound heterozygote (in the patients) or a simple heterozygote (in one parent). Each of the compound heterozygous mutations contributed additively to the pathological condition seen in the patients, and the more detrimental of the two mutations, C94S, may cause (partial) primary GHI, even in a heterozygous state.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013798726

Download citation: RISBibTeXText

PMID: 17405847

DOI: 10.1210/jc.2006-2624


Related references

Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 82(11): 3705-3709, 1997

Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain. Hormone Research in Paediatrics 74(6): 406-411, 2011

Novel compound heterozygous mutations of the growth hormone-releasing hormone receptor gene in a case of isolated growth hormone deficiency. Growth Hormone and Igf Research 23(4): 89-97, 2014

Severe short stature caused by novel compound heterozygous mutations of the insulin-like growth factor 1 receptor (IGF1R). Journal of Clinical Endocrinology and Metabolism 97(2): E243-E247, 2012

Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations. Journal of Clinical Endocrinology and Metabolism 93(3): 1030-1037, 2007

A case with isolated growth hormone deficiency caused by compound heterozygous mutations in GH-1: a novel missense mutation in the initiation codon and a 7.6kb deletion. Growth Hormone & Igf Research 17(3): 249-253, 2007

A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V gene. Haemophilia 12(2): 172-178, 2006

SOPH Syndrome with Growth Hormone Deficiency, Normal Bone Age, and Novel Compound Heterozygous Mutations in NBAS. Fetal and Pediatric Pathology 2018: 1-7, 2018

A case of isolated growth hormone (GH) deficiency with compound heterozygous abnormality at the GH-1 gene locus. Journal of Pediatric Endocrinology & Metabolism 10(1): 73-76, 1997

Type Ia isolated growth hormone deficiency (Ighd) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the Gh1 gene locus. Arquivos Brasileiros de Endocrinologia & Metabologia 56(8): 558-563, 2012

Type IA isolated growth hormone deficiency (IGHD) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the GH1 gene locus. Arquivos Brasileiros de Endocrinologia E Metabologia 56(8): 558-563, 2013

The first confirmed case with C3 deficiency caused by compound heterozygous mutations in the C3 gene; a new aspect of pathogenesis for C3 deficiency. Blood Cells, Molecules and Diseases 40(3): 410-413, 2008

A case of factor XI deficiency caused by compound heterozygous F11 gene mutation. Haemophilia 15(2): 603-606, 2009

Type I coagulation factor V deficiency caused by compound heterozygous mutation of F5 gene. Haemophilia 9(5): 646-649, 2003

Compound heterozygous mutations Glu502Lys and Met527Thr of the FXII gene in a patient with factor XII deficiency. Hematology 24(1): 420-425, 2019